RELAY THERAPEUTICS INC (RLAY)

US75943R1023 - Common Stock

4.345  -0.44 (-9.1%)

After market: 4.2555 -0.09 (-2.06%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
35.55M25.55M1.38M3.03M82.65M
Operating Expenses
696.04M398.55M300.66M355.87M138.45M
Research and Development
581.03M330.02M246.36M292.53M96.97M
Selling, General, and Administrative Expenses
134.64M74.95M65.98M57.39M38.59M
Operating Income
-660.49M-373.00M-299.28M-352.84M-55.80M
Interest Income/Expense
56.82M31.05M8.79M-11.03M3.40M
Other Income/Expense
-5.00K-18.00K-20.00K0.00-20.00K
Non Recurring Items
N/A0.00N/AN/AN/A
Income Before Taxes
-603.68M-341.97M-290.51M-363.87M-52.41M
Net Income
-603.68M-341.97M-290.51M-363.87M-230.20M
EBITDA
-654.98M-367.73M-295.15M-348.91M-52.25M
 
Per Share Data
EPS Diluted Total Ops
-4.73-2.79-2.59-3.82-2.56
Non GAAP EPS
-2.61-2.80-2.60-3.85N/A
 
Statistics
Profit Margin
-1697.96%-1338.66%-21051.45%-12008.91%-278.52%
Operating Profit Margin
-1857.76%-1460.11%-21686.96%-11644.88%-67.51%

All data in USD

Charts